We are live on
!
Find out more
JP
JNE Partners Portfolio holdings
AUM
$244M
1-Year Est. Return
15.73%
This Fund
S&P 500
This Quarter
Est. Return
+16.38%
1 Year Est. Return
+15.73%
3 Year Est. Return
+98.55%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$56.7M
(+30%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
8.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$21.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 88.9% |
| 2 | Healthcare | 8.94% |
| 3 | Materials | 2.15% |
Similar funds
LC
IAMOG
RI
CA
LHCM
BNMT
BB
GIM
JNE Partners's Q2 2025 Portfolio in Review
As of Q2 2025, JNE Partners held 8 positions worth $249M, up 30% from $192M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
JNE Partners deployed $21.8M of net new capital in Q2 2025, opening 1 new position. Its largest new stake was Bio-Rad Laboratories Class A: 92,100 shares worth $22.2M.
By sector, the portfolio is most concentrated in Communication Services at 89% of assets, down from 98% a quarter earlier, followed by Healthcare and Materials.
- JNE Partners's largest Q2 2025 buy was Bio-Rad Laboratories Class A: 92,100 shares worth $22.2M.
- JNE Partners's ten largest holdings make up 100% of its $249M portfolio in Q2 2025.
- JNE Partners opened 1 new position and closed 0 in Q2 2025.
- JNE Partners's portfolio value rose 30% quarter-over-quarter to $249M.
Based on JNE Partners's 13F filing for Q2 2025, filed 14 Aug 2025.